Dashboard
Manage Tickers

ADMA ADMA BIOLOGICS, INC.


$ 14.05 $ -1.34 (-8.72 %)    

Thursday, 06-Nov-2025 16:16:36 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.00 nm (nm)
DIA $ 469.80 $ -3.83 (-0.81 %)
SPY $ 671.74 nm (nm)
TLT $ 89.73 nm (nm)
GLD $ 365.79 $ -0.44 (-0.12 %)
$ 14.03
$ 14.85
$ 14.03 x 33
$ 15.25 x 200
$ 13.83 - $ 15.24
$ 13.50 - $ 25.67
9,489,860
na
nm
$ 0.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

update-adma-biologics-q3-adj-eps-016-beats-015-estimate-sales-134224m-beat-130533m-estimate
UPDATE: ADMA Biologics Q3 Adj. EPS $0.16 B...
11/05/2025 23:18:28

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 ...

adma-biologics-fy2026--revenue-expected-to-be-at-least-630000m-vs-637727m-est
ADMA Biologics FY2026 Revenue expected to...
11/05/2025 21:18:06

ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $630.000M vs $637.727M Est

adma-biologics-fy2025--revenue-expected-to-be-at-least-510000m-vs-506202m-est
ADMA Biologics FY2025 Revenue expected to...
11/05/2025 21:14:15

ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $510.000M vs $506.202M Est

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

adma-biologics-option-alert-nov-21-15-calls-sweep-8-near-the-ask-2000--1076-vs-372-oi-earnings-116-after-close-est-ref14225
ADMA Biologics Option Alert: Nov 21 $15 Ca...
10/08/2025 17:18:22

redwire-posts-downbeat-q2-results-joins-tandem-diabetes-care-fortinet-symbotic-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Redwire Posts Downbeat Q2 Results, Joins T...
08/07/2025 12:14:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

why-groupon-shares-are-trading-higher-by-around-28-here-are-20-stocks-moving-premarket
Why Groupon Shares Are Trading Higher By A...
08/07/2025 09:41:13

adma-biologics-sees-fy2026-sales-500000m-625000m-vs-64117m-est
ADMA Biologics Sees FY2026 Sales $500.000M...
08/06/2025 20:43:18

ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $500.000 million-$625.000 million vs $641.17 million analyst estimate.

adma-biologics-sees-fy2025-sales-500000m-625000m-vs-50767m-est
ADMA Biologics Sees FY2025 Sales $500.000M...
08/06/2025 20:43:08

ADMA Biologics (NASDAQ:ADMA) sees FY2025 sales of $500.000 million-$625.000 million vs $507.67 million analyst estimate.

adma-biologics-q2-adj-eps-014-inline-sales-12198m-miss-12267m-estimate
ADMA Biologics Q2 Adj. EPS $0.14, Inline, ...
08/06/2025 20:07:37

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

is-adma-biologics-gaining-or-losing-market-support
Is ADMA Biologics Gaining or Losing Market...
08/01/2025 13:00:25

is-adma-biologics-gaining-or-losing-market-support
Is ADMA Biologics Gaining or Losing Market...
07/02/2025 18:00:33

how-is-the-market-feeling-about-adma-biologics
How Is The Market Feeling About ADMA Biolo...
06/04/2025 16:00:37

raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-32
Raymond James Maintains Strong Buy on ADMA...
05/08/2025 17:26:36

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

crude-oil-gains-over-2-us-foods-posts-downbeat-earnings
Crude Oil Gains Over 2%; US Foods Posts Do...
05/08/2025 16:46:42

adma-biologics-fy2026--revenue-expected-to-be-more-than-62500m-vs-62923m-est
ADMA Biologics FY2026 Revenue expected to...
05/07/2025 20:16:02

ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

adma-biologics-fy2025--revenue-expected-to-be-more-than-50000m-vs-49510m-est
ADMA Biologics FY2025 Revenue expected to...
05/07/2025 20:15:49

ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

adma-biologics-q1-adj-eps-014-misses-016-estimate-sales-11480m-miss-11640m-estimate
ADMA Biologics Q1 Adj. EPS $0.14 Misses $0...
05/07/2025 20:15:00

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.1...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION